(Q34994568)

5 August 2017

title

Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial (English)

1 reference

randomized controlled trial

5 August 2017

main subject

1 reference

Chris Jacobs

15

0 references

Usha Menon

object named as

Usha Menon

19

0 references

Jane Wardle

5

object named as

Jane Wardle

1 reference

5 August 2017

16

Ian Tomlinson

1 reference

5 August 2017

Alistair McGuire

17

0 references

Yvonne Wallis

12

object named as

Yvonne Wallis

1 reference

5 August 2017

1

Ranjit Manchanda

1 reference

5 August 2017

8

Nyala Balogun

1 reference

5 August 2017

2

Kelly Loggenberg

1 reference

5 August 2017

Saskia Sanderson

3

1 reference

5 August 2017

Matthew Burnell

4

1 reference

5 August 2017

Sue Gessler

6

1 reference

5 August 2017

Lucy Side

7

1 reference

5 August 2017

Rakshit Desai

9

1 reference

5 August 2017

Ajith Kumar

10

1 reference

5 August 2017

Huw Dorkins

11

1 reference

5 August 2017

Cyril Chapman

13

1 reference

5 August 2017

Rohan Taylor

14

1 reference

5 August 2017

Uziel Beller

18

1 reference

5 August 2017

Ian Jacobs

20

1 reference

5 August 2017

language of work or name

English

0 references

publication date

30 November 2014

1 reference

Journal of the National Cancer Institute

5 August 2017

published in

1 reference

5 August 2017

volume

107

1 reference

5 August 2017

issue

1

1 reference

5 August 2017

page(s)

379

1 reference

Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301703

Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301703

Next-generation DNA sequencing

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301703

Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301703

Limited family structure and BRCA gene mutation status in single cases of breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301703

Cancer genetic risk assessment for individuals at risk of familial breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301703

Meta-analysis of BRCA1 and BRCA2 penetrance

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301703

Evaluation of models to predict BRCA germline mutations

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301703

Case-control and case-only designs with genotype and family history data: estimating relative risk, residual familial aggregation, and cumulative risk

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301703

A literature review of the psychological impact of genetic testing on breast cancer patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301703

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301703

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301703

Evaluation of abnormal mammography results and palpable breast abnormalities

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301703

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301703

Normative data for the HADS from a large non-clinical sample.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301703

Association and aggregation analysis using kin-cohort designs with applications to genotype and family history data from the Washington Ashkenazi Study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301703

The frequency of founder mutations in the BRCA1, BRCA2, and APC genes in Australian Ashkenazi Jews: implications for the generality of U.S. population data

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301703

Development and testing of the UK SF-12 (short form health survey).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301703

The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301703

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301703

A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301703

The hospital anxiety and depression scale

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301703

Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies

8 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU379

Risk reducing mastectomy: outcomes in 10 European centres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU379

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU379

Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU379

A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU379

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU379

Psychological impact of genetic testing in women from high-risk breast cancer families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU379

Psychological impact of receiving negative BRCA1 mutation test results in Ashkenazim.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU379

Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU379

Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU379

Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU379

Assessing BRCA carrier probabilities in extended families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU379

A marginal likelihood approach for estimating penetrance from kin-cohort designs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU379

Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301703

Familial context of genetic testing for cancer susceptibility: moderating effect of siblings' test results on psychological distress one to two weeks after BRCA1 mutation testing.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301703

Genetic epidemiology of BRCA mutations – family history detects less than 50% of the mutation carriers

26 October 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU379

The Health Anxiety Inventory: development and validation of scales for the measurement of health anxiety and hypochondriasis

21 January 2018

1 reference

12 December 2020

Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer

1 reference

12 December 2020

Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study

1 reference

12 December 2020

Psychological impact of genetic testing for breast cancer susceptibility in women of Ashkenazi Jewish background: a prospective study

1 reference

12 December 2020

The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal?

1 reference

12 December 2020

Patient satisfaction and cancer-related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJU379

1 reference

5 August 2017

1 reference

5 August 2017

1 reference